The study, titled “Exhaled volatile organic compounds identify patients with colorectal cancer,” was published in the British Journal of Surgery.
The study’s results show colorectal cancer patients have a different volatile organic compound pattern compared with healthy controls, based on analysis of compounds in exhaled breath samples. The probabilistic neural network used in the study was able to identify patients with colorectal cancer with more than 75 percent accuracy.
Related Articles on Colorectal Cancer:
AGA Partners With CDC to Expand CRC Screening
Study: Mistletoe Extract Effective Against Colon Cancer Cells
Study: Aspirin May Increase Colon Cancer Survival Rate
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
